Your sister is on the phone, repeating what the neurologist said about the new infusion, and you can hear the hope in her voice as she says the word “amyloid.” She wants to know if this one is different, if this one actually fixes it. You want to say yes, but the question hangs there, unanswered.
You are standing in the kitchen with a pill bottle in your hand, trying to remember whether you already took the morning dose. The label has a generic name you cannot pronounce, and the neurologist said something about what it does, but the words have blurred into a single anxious question: is this actually doing anything? That tension, between hope and the limits of what a drug can change, sits at the center of every conversation about Alzheimer’s medication. The useful answer is that there are three main classes of approved drugs, and they do different things. Cholinesterase inhibitors and memantine can temporarily ease or slow certain symptoms for some people. Anti-amyloid infusions target a protein involved in the disease process, but they carry serious risks and do not restore lost memory. None of these medicines cures Alzheimer’s, and none can reverse the damage already done.
Cholinesterase inhibitors work on a chemical messenger
The first group of medicines is called cholinesterase inhibitors. They act on acetylcholine, a chemical messenger involved in memory and learning. In Alzheimer’s disease, brain cells that produce acetylcholine are damaged, so levels of this messenger fall. These drugs slow the breakdown of acetylcholine, leaving more of it available between nerve cells. The effect is modest and temporary. For some people, symptoms such as memory loss and confusion may improve for a while, or decline more slowly than they otherwise would. For others, the benefit is hard to notice.
These medicines are used in mild to moderate Alzheimer’s disease. They are taken by mouth, usually as a tablet or a patch placed on the skin. Common side effects include nausea, vomiting, diarrhea, loss of appetite, and muscle cramps. Because they affect the digestive system, they are often started at a low dose and increased gradually. A doctor will monitor weight, heart rate, and any fainting or stomach problems. The drugs do not stop the underlying loss of brain cells, so any benefit fades as the disease progresses.
Memantine works on a different pathway
Memantine is approved for moderate to severe Alzheimer’s disease. It works on glutamate, another chemical messenger. In Alzheimer’s, too much glutamate can overstimulate nerve cells and contribute to damage. Memantine blocks some of that overactivity without stopping normal signalling entirely. The result is a small effect on daily function, alertness, or behavior in some people.
Memantine is taken by mouth, often as a tablet or liquid. Common side effects include dizziness, headache, constipation, and confusion. It is sometimes prescribed alongside a cholinesterase inhibitor, because the two drugs act on different systems. A doctor will check kidney function before and during treatment, since the dose may need to be lower for someone with reduced kidney function. Like the cholinesterase inhibitors, memantine does not change the course of the disease.
What can Alzheimer’s drugs do?What if the drug isn’t failingWatch the video to see the pattern behind that question, and why it keeps coming back.
Anti-amyloid infusions target a protein, not a symptom
A newer class of medicines is given by intravenous infusion. These anti-amyloid drugs are antibodies that attach to beta-amyloid protein, which clumps into plaques in the brains of people with Alzheimer’s. The aim is to help the immune system clear some of that amyloid. In trials, the drugs reduced amyloid plaques on brain scans. What that means for daily memory and thinking is less clear. Some trials showed a small slowing of decline on certain cognitive tests, but the difference was modest and not everyone benefited.
The risks are significant. The most serious side effects are swelling or bleeding in the brain, which can be detected on MRI scans. Some people have no symptoms from these changes, while others develop headache, confusion, dizziness, nausea, or seizures. Because of this, people receiving these infusions need regular brain scans and close monitoring. The medicines are not for everyone. They are generally considered for people in the early stages of Alzheimer’s with evidence of amyloid in the brain, and the decision depends on a person’s age, other health conditions, and willingness to accept the risks.
What none of the medicines can do yet
No approved Alzheimer’s medicine cures the disease, reverses memory loss, or brings back skills that are already gone. The cholinesterase inhibitors and memantine may ease symptoms for a time. The anti-amyloid infusions may slow decline slightly in some people, but they do not stop the disease. The evidence does not show that any of these drugs restore a person to their previous level of function.
What each drug class does
| Drug class | Acts on | Stage | What it cannot do |
|---|---|---|---|
| Cholinesterase inhibitors | Acetylcholine | Mild to moderate | Stop brain cell loss |
| Memantine | Glutamate | Moderate to severe | Change the disease course |
| Anti-amyloid infusions | Beta-amyloid protein | Early stage | Restore lost memory |
This is the hardest part for families to hold. A person may still get worse while taking medication, and that does not mean the medicine is failing or was the wrong choice. It means the disease is progressing. The goal of treatment is often to preserve what remains for as long as possible, reduce distress, and plan for care. A doctor can help weigh the possible benefit of each drug against its side effects and the burden of monitoring.
The mistake people make with supplements
A common mistake is to assume that a dietary supplement can do the same job as a prescribed medicine, or that taking a supplement means a medicine can be stopped. The evidence does not support this. Supplements are not regulated the way prescription drugs are, and studies have not shown that any supplement treats Alzheimer’s disease. Some can interact with prescribed medicines or cause side effects.
If a person is taking a prescribed Alzheimer’s medicine, it should not be stopped or swapped for a supplement without talking to the doctor who prescribed it. The safest route is to tell the doctor about everything the person is taking, including vitamins, herbs, and over-the-counter products.
Before you put this down to a busy week, watch the full video about the pattern these moments can form.
The slip in this article may be the small version of a pattern that keeps returning, and it is worth seeing it clearly watch the full video before the next conversation begins.
Everything on Memory loss & dementia →
▶ Watch the memory video
